Cell culture studies of a carborane cholesteryl ester with conventional and PEG liposomes

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 10, Issue 1, 2003, Pages 29-34

  Peacock, G F ^a   Ji, B ^b   Wang, C K ^c   Lu, D R ^b  

^a SHENANDOAH UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Boron; Cholesterol; Liposomes; Low Density Lipoprotein; Polyethylene Glycol (PEG); Tumor; Uptake

Indexed keywords

BORON; CARBORANE DERIVATIVE; CHOLESTEROL; CHOLESTEROL ESTER; DIPALMITOYLPHOSPHATIDYLCHOLINE; MACROGOL; MACROGOL 2000; PHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL CULTURE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; DRUG UPTAKE; EVALUATION; GLIOMA CELL; GROWTH STIMULATION; INCUBATION TIME; LIPID SOLUBILITY; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR;

EID: 0037273197     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/713840324     Document Type: Article

References (35)

1. Anisuzzaman, A. K. M., Alam, F., and Soloway, A. H. 1990. Synthesis of a carboranyl nucleoside for potential use in neutron capture therapy of cancer. Polyhedron 9:891-892.
2. Asbury, A. K., Ojeann, R. G., Nielsen, S. L., and Sweet, W. H. 1966. Neuropathologic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation. J. Neuropathol. Exp. Neurol. 31:278-303.
3. Barth, R. F., Soloway, A. H., Fairchild, R. F., and Brugger, R. M. 1992. Boron neutron capture therapy for cancer: Realities and prospects. Cancer 70(12):2995-3007.
4. Brown, M. S., and Goldstein, J. L. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47.
5. Brown, M. S., Kovanen, P. T., and Goldstein, J. L. 1980. Evolution of the LDL receptor concept - from cultured cells to intact animals. Ann. N.Y. Acad. Sci. 348:48.
6. Brown, M. S., Kovanen, P. T., and Goldstein, J. L. 1981. Regulation of plasma cholesterol by lipoprotein receptors. Science 212:628.
7. Callahan, D. E., Forte, T. M., Afzal, S. M., Deen, D. F., Kahl, S. B., Bjomstad, K. A., Bauer, W. F., and Blakely, E. A. 1999. Boronated protoporphyrin BOPP): Localization in lysosomes of the human glioma cell line SF-767 with uptake modulated by lipoprotein levels. Int. J. Radi. Oncol. Biol. Phys. 45:761-771.
8. Chen, W., Mehta, S., and Lu, D. R. 1997. Selective boron drug delivery to brain tumors for boron neutron capture therapy. Adv. Drug Del. Rev. 26:231-247.
9. Entzian, W., Soloway, A. H., Raju, R., Sweet, W. H., and Brownell, G. L. 1966. Effect of neutron capture irradiation upon malignant brain tumors in mice. Acta Radiol. 5:95-100.
10. Fairchild, R. G., Kahl, S. B., Laster, B. H., Kalef-Ezra, J., and Popenoe, E. A. 1990. In vitro determination of uptake, retention, distribution, biological efficacy and toxicity of boronated compounds for neutron capture therapy: A comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res. 50:4860-4865.
11. Firestone, R. A. 1994. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconj. Chem. 5:105-113.
12. Goldstein, J. L., Anderson, R. G. W., and Brown, M. S. 1979. Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279:679-685.
13. Gutman, R. L., Peacock, G., and Lu, D. R. 2000. Targeted drug delivery for brain cancer treatment. J. Cont. Rel. 65:31-41.
14. Ho, Y. K., Smith, R. G., Brown, M. S., and Goldstein, J. L. 1978. Low-density lipoprotein (LDL) receptor activity in acute myelogenous leukemia cells. Blood 52:1099-1114.
15. 10B-para-boronophenylalanine in thermal neutron capture therapy of malignant melanoma: In vivo radiobiological evaluation. J. Invest. Dermatol. 78:215-218.
16. Ji, B., Peacock, G., and Lu, D. R. 2002. Synthesis of cholesterol-carborane conjugate for targeted drug delivery. Bioorganic & Medicinal Chemistry Letters, 12:2455-2458.
17. Kader, A., Davis, P. J., Kara, M., and Liu, H. 1998. Drug targeting using low density lipoprotein (LDL): Physicochemical factors affecting drug loading into LDL particles. J. Cont. Rel. 55:231-243.
18. Lasic, D. D. 1996. Doxorubicin in sterically stabilized liposomes. Nature 380:561-562.
19. Laster, B. H., Kahl, S. B., Popenoe, E. A., Pate, D. W., and Fairchild, R. G. 1991. Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture. Cancer Res. 51(17):4588-4593.
20. Lenz, M., et al. 1997. Cholesterol based antineoplastic strategies. Anticancer Res. 17:1143-1146.
21. Lu, D. R., and Ji, B. 2000. Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery. U.S. Patent No. 6,392,068.
22. Maletinska, L., Blakely, E. A., Bjomstad, K. A., Deen, D. F., Knoff, L. J., and Forte, T. M. 2000. Human glioblastoma cell lines: Levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res. 60:2300-2303.
23. Maruyama, K., Tsutomu, Y., Okamoto, A., Kojima, S., Suginaka, A., and Iwatsuru, M. 1992. Prolonged circulation time in vivo of large unilamellar liposomes composed composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim. Biophys. Acta 1128:44-49.
24. Mehta, S., Lai, J. C. K., and Lu, D. R. 1996. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy. J. Microencap. 13(3):269-279.
25. Murakami, M., Ushio, Y., Mihara, Y., Kuratsu, J., Horiuchi, S., and Morino, Y. 1990. Cholesterol uptake by human glioma-cell via receptor-mediated endocytosis of low-density lipoprotein. J. Neurosurg. 73:760-767.
26. Nygren, C., Holst, H. V., Manson, J., and Fredman, P. 1997. Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain. Bri. J. Neurosurg. 11(3):216-220.
27. Rudling, M. J., Angelin, B., Peterson, C. O., and Collins, V. P. 1990. Low-density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement. Cancer Res. 50:483-487.
28. Schinazi, R. F., and Prusoff, W. H. 1978. Synthesis and properties of boron and silicon substituted uracil or 2-deoxyuridine. Tetrahed. Lett. 50: 4981-4984.
29. Slatkin, D. N. 1991. A history of boron neutron capture therapy of brain tumors. Brain 114:1609-1629.
30. Soloway, A. H. 1964. Boron compounds in cancer therapy. In Progress in Boron Chemistry, ed. H. Steinberg and A. L. McCloskey, 203-234. New York, NY: Pergamon Press.
31. Spielvogel, B. F., Good, A., Hall, I. H., Fairchild, R. G., and Micca, P. L. 1989. Synthesis, antineoplastic activity and biodistribution of boron analogues of amino acids and related compounds. Strahlenther und Onkol 5:123-125.
32. Sweet, W. H., Soloway, A. H., and Brownell, G. H. 1963. Boron-slow neutron capture therapy of gliomas. Acta Radiol. 1: 114-121.
33. Tjarks, W., and Gabel, D. 1991. Boron-containing thiouracil derivatives for neutron-capture therapy of melanoma. J. Med. Chem. 34:315-319.
34. Vitols, S., Gahrton, G., Ost, A., and Peterson, C. 1984. Elevated low-density lipoprotein receptor activity in leukemic cells with monocytic differentaition. Blood 63:1186-1193.
35. Vitols, S., Peterson, C., Larsson, O., Holm, P., and Aberg, B. 1987. Elevated uptake of low-density lipoproteins by human lung cancer tissue in vivo. Cancer Res. 47:4105-4108.